Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Tritriacontanoic Acid
Therapeutic Area : Endocrinology
Study Phase : Phase IV
Sponsor : Bukwang Pharmaceutical Co., Ltd | ChunLab, Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Dietary Fiber on Glucose Control in Subjects With Type 2 Diabetes Mellitus
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
June 12, 2018
Lead Product(s) : Tritriacontanoic Acid
Therapeutic Area : Endocrinology
Highest Development Status : Phase IV
Sponsor : Bukwang Pharmaceutical Co., Ltd | ChunLab, Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Tritriacontanoic Acid
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Ironwood Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
MRI and Microbiota Analysis in Constipation
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
May 22, 2014
Lead Product(s) : Tritriacontanoic Acid
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Ironwood Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Tritriacontanoic Acid
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Ironwood Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Ispaghula and Colonic Water Content
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
March 06, 2013
Lead Product(s) : Tritriacontanoic Acid
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Ironwood Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable